C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2439291
This invention relates to the use of compounds of the general formula wherein R1 and R2 signify hydrogen, (C1-6)-alkyl, halogen, hydroxy, (C1-6)-alkoxy and A has the significance given in the description, as well as pharmaceutically acceptable salts thereof, for the manufacture of medicaments for the treatment or prevention of GluR5 receptor mediated disorders, such as acute and/or chronic neurological disorders.
L'invention se rapporte à l'utilisation de composés de formule générale I dans laquelle R?1¿ et R?2¿ désignent un hydrogène, un alkyle C1-6, un halogène, un hydroxy, un alcoxy avec C1-6 et A est tel que décrits dans les revendications. L'invention se rapporte également à des sels pharmaceutiquement acceptables dérivés des composés permettant d'obtenir des médicaments pour le traitement ou la prévention de troubles induits par le récepteur mGluR5, notamment les troubles nerveux aigus et/ou chroniques.
Mutel Vincent
Peters Jens-Uwe
Wichmann Juergen
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1758915